News Jan 26, 2022 Basel Area – exactly the right chemistry for South Korean pharma companies KPBMA and Basel Area Business & Innovation establish tailored collaboration to support Korean biopharmaceutical companies to enter the Europe...
News Jan 26, 2022 Ideogen improving accessibility of blood cancer therapy The Ideogen Group from the Greater Zurich Area is taking over the Special Access Program for Beleodaq in Europe, North Africa, the Middle East an...
News Jan 12, 2022 ObsEva achieves positive results in the treatment of endometriosis Geneva-based women’s health biopharmaceutical company ObsEva has announced positive topline results from the Phase 3 EDELWEISS 3 trial of linzago...
News Dec 20, 2021 Investors give Anaveon 110 million Swiss francs Anaveon has received investment commitments amounting to 110 million Swiss francs in a Serie B funding round. The biopharmaceutical company can u...
News Dec 16, 2021 Basel alliance seeks to combat antibiotic resistance The SPEARHEAD alliance has been founded in Basel with the aim of combating the silent pandemic of antimicrobial resistance. By 2050, this will ca...
News Dec 14, 2021 Pharma group Siegfried invests in Valais and creates 40 jobs Siegfried will build a research and development laboratory in Evionnaz, an investment of tens of millions of Swiss francs resulting in the creati...
News Dec 06, 2021 Roche tests able to detect Omicron The Roche subsidiary TIB Molbiol has developed new coronavirus testing kits that can also detect the new Omicron variant of the disease. These te...
News Dec 01, 2021 Sun Genomics sets up European subsidiary in Fribourg Probiotics specialist Sun Genomics has chosen Fribourg to set up its European subsidiary. This is the first establishment of a US company in West...
News Nov 30, 2021 Hemex banks 7.1 million Swiss francs Hemex has raised a total of 7.1 million Swiss francs as part of a Series C financing round. The company for clinical contract research and invest...
News Nov 17, 2021 Inflamalps takes part in a significant biopharmaceutical research project Biopharmaceutical company Inflamalps has just entered a major Innosuisse project, which aims to discover at least one new class of antimicrobial ...
News Nov 12, 2021 Bachem lays foundation stone for production building Bachem has laid the foundation stone for its largest production building to date. The company specializing in the manufacture of peptides and oli...
News Nov 10, 2021 Geistlich Pharma’s collagen membrane authorized for use in the USA The Geistlich Nexo-Gide has obtained clearance from the US Food and Drug Administration (FDA). The collagen membrane developed by Geistlich Pharm...
News Oct 13, 2021 Valais biotech Novochizol wins an international competition Novochizol, a biotech company with a unique chitosan-based drug formulation nanotechnology, has been selected by Boehringer Ingelheim as one of t...
News Oct 05, 2021 UNIGE and FONGIT strengthen their support to start-ups The University of Geneva (UNIGE) and FONGIT are strengthening their collaboration to provide additional support to Geneva-based start-ups.
News Sep 30, 2021 Basel Area becomes the Swiss hotspot for Chinese pharma companies More and more Chinese pharmaceutical companies are choosing the Basel Area as location for their subsidiary in Switzerland. Among them is Hengrui...
News Sep 29, 2021 Researchers find proof of dementia in the blood The scientist Peter Nirmalraj is seeking to develop a simple blood test to help diagnose dementia. A pilot study carried out in conjunction with ...
News Sep 27, 2021 University of Bern spin-off Arctos Medical acquired by Novartis Arctos Medical, a University of Bern spin-off developing optogenetic therapies for treating blindness, was acquired by Novartis.
News Sep 24, 2021 Lonza builds new filling line in Stein Lonza is investing in the development and manufacture of medicinal products in Switzerland. The pharmaceutical supplier is constructing a new fil...